1. Nonclinical considerations for mitigating nonhuman primate supply constraints arising from the COVID-19 pandemic Publication: Silver Spring, MD : Center for Drug Evaluation and Research, February 2022 Subject(s): Biological ProductsDrug Evaluation, PreclinicalPrimatesCOVID-19United StatesUnited States. Department of Health and Human ServicesUnited States. Food and Drug Administration
